Our group has previously employed gene-deleted mice in combination with specific pharmacologic inhibitors to identify C3 as the central mediator of complement-induced acute cerebral ischemic injury following reperfused stroke in mice [14]. This evidence concerns the gene C3 and stroke disorder.